Sivik Global Healthcare’s Kite Pharma, Inc. KITE Stock Holding History

Sivik Global Healthcare’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-8,000	Closed	-$1.44M	–	89
2017 Q3	$1.44M	Sell	8,000 -10,000	-56%	-$1.39M	0.49%	66
2017 Q2	$1.87M	Hold	18,000	–	–	0.68%	52
2017 Q1	$1.41M	Hold	18,000	–	–	0.66%	52
2016 Q4	$807K	Buy	18,000 +3,000	+20%	+$147K	0.39%	53
2016 Q3	$838K	Sell	15,000 -5,000	-25%	-$279K	0.42%	45
2016 Q2	$1M	Sell	20,000 -10,000	-33%	-$491K	0.5%	54
2016 Q1	$1.38M	Buy	+30,000	New	+$1.45M	0.61%	54

Sivik Global Healthcare's KITE Position: Q4 2017 in Review

Sivik Global Healthcare sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 8,000 shares — an estimated $1.44M sold.

Sivik Global Healthcare first reported a position in KITE in Q1 2016 and held it in 7 quarters. The position peaked at $1.87M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Sivik Global Healthcare reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Sivik Global Healthcare sold 8,000 Kite Pharma, Inc. shares in Q4 2017, an estimated $1.44M.
Sivik Global Healthcare first reported a position in Kite Pharma, Inc. in Q1 2016 and held it in 7 quarters.
Sivik Global Healthcare's Kite Pharma, Inc. position peaked at $1.87M in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Sivik Global Healthcare's 13F filing for Q4 2017, filed 8 Feb 2018.